MLS-101

· Mineralys Therapeutics Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLS-101, covering 2024-01-05 to 2024-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension [Phase 2]